Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-14

FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Alfuzosin hydrochloride from Aurobindo Pharma Limited, indicating regulatory approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride)

Snippet

SUPPL AP for ALFUZOSIN HYDROCHLORIDE (ALFUZOSIN HYDROCHLORIDE)